Reduced-intensity conditioning with thiotepa, fludarabine and melphalan is an effective regimen for allogeneic transplantation in multiple myeloma

被引:0
|
作者
Majolino, I
Arana, MG
Riccardi, M
Locasciulli, A
Bacigalupo, A
Di Bartolomeo, P
Scimè, R
Olivieri, A
Narni, F
Bregni, M
De Fabritiis, P
Musso, M
Corradini, P
机构
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S70 / S70
页数:1
相关论文
共 50 条
  • [41] Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma
    Epperla, Narendranath
    Ahn, Kwang Woo
    Armand, Philippe
    Jaglowski, Samantha
    Ahmed, Sairah
    Kenkre, Vaishalee P.
    Savani, Bipin
    Jagasia, Madan
    Shah, Nirav N.
    Fenske, Timothy S.
    Sureda, Anna
    Smith, Sonali M.
    Hamadani, Mehdi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (01) : 78 - 85
  • [42] ALLOGENEIC REDUCED-INTENSITY STEM CELL TRANSPLANTATION WITH FLUDARABINE AND MELPHALAN FOR REFRACTORY OR RELAPSED FOLLICULAR LYMPHOMA
    Ono, Y.
    Mori, T.
    Kato, J.
    Aisa, Y.
    Okamoto, S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S236 - S236
  • [43] Reduced-intensity allogeneic hematopoietic cell transplantation using fludarabine–melphalan conditioning for treatment of mature T-cell lymphomas
    M Delioukina
    J Zain
    J M Palmer
    N Tsai
    S Thomas
    S Forman
    Bone Marrow Transplantation, 2012, 47 : 65 - 72
  • [44] Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome
    Nakamura, R.
    Rodriguez, R.
    Palmer, J.
    Stein, A.
    Naing, A.
    Tsai, N.
    Chang, K.
    Slovak, M. L.
    Bhatia, R.
    Spielberger, R.
    Kogut, N.
    Pullarkat, V.
    Kirschbaum, M.
    Forman, S. J.
    O'Donnell, M. R.
    BONE MARROW TRANSPLANTATION, 2007, 40 (09) : 843 - 850
  • [45] Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome
    R Nakamura
    R Rodriguez
    J Palmer
    A Stein
    A Naing
    N Tsai
    K Chang
    M L Slovak
    R Bhatia
    R Spielberger
    N Kogut
    V Pullarkat
    M Kirschbaum
    S J Forman
    M R O'Donnell
    Bone Marrow Transplantation, 2007, 40 : 843 - 850
  • [46] Reduced-intensity Conditioning Allogeneic Stem Cell Transplantation in Myeloma: A Prospective Trial
    Gahrton, G.
    Bjoerkstrand, B.
    Iacobelli, S.
    Hegenbart, U.
    Gruber, A.
    Greinix, H.
    Volin, L.
    Narni, F.
    Musto, P.
    Beksac, M.
    Bosi, A.
    Milone, G.
    Corradini, P.
    Goldschmidt, H.
    de Witte, T.
    Morris, C.
    Niederwieser, D.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S9 - S10
  • [47] Treosulfan/fludarabine as conditioning regimen for allogeneic stem cell transplantation in multiple myeloma.
    Knauf, WU
    Blau, W
    Ruutu, T
    Einsele, H
    Thiel, E
    Freund, M
    Casper, J
    BLOOD, 2003, 102 (11) : 711A - 711A
  • [48] Reduced-intensity allogeneic haematopoietic stem cell transplantation for multiple myeloma
    Kikuchi, T.
    Mori, T.
    Kato, J.
    Yamane, A.
    Ono, Y.
    Kunimoto, H.
    Okamoto, S.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S264 - S264
  • [49] Reduced-Intensity Conditioning with Fludarabine, Melphalan, and Total Body Irradiation for Allogeneic Hematopoietic Cell Transplantation: The Effect of Increasing Melphalan Dose on Underlying Disease and Toxicity
    Chen, George L.
    Hahn, Theresa
    Wilding, Gregory E.
    Groman, Adrienne
    Hutson, Alan
    Zhang, Yali
    Khan, Usman
    Liu, Hong
    Ross, Maureen
    Bambach, Barbara
    Higman, Meghan
    Neppalli, Vishala
    Sait, Sheila
    Block, AnneMarie W.
    Wallace, Paul K.
    Singh, Anurag K.
    McCarthy, Philip L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (04) : 689 - 698
  • [50] Reduced intensity conditioning with fludarabine and thiotepa for second allogeneic transplantation of relapsed patients with acute myeloid leukaemia
    Christopoulos, P.
    Schmoor, C.
    Waterhouse, M.
    Marks, R.
    Waesch, R.
    Bertz, H.
    Finke, J.
    ONKOLOGIE, 2012, 35 : 129 - 129